Clinical trial
Longitudinal Imaging Biomarkers of Disease Progression in DLB
NCT03582488 is registered in ClinicalTrials.gov with Kejal Kantarci as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Imaging Biomarkers of Disease Progression in DLB
- Lead sponsor
- Kejal Kantarci
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- June 25, 2018
- Completion date
- September 30, 2027
- Enrollment
- 135 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.